Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2023);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;%Female;Overton;SDG;Country;Region;Publisher;Coverage;Categories;Areas 1;22358;"U.S. Pharmacist";trade journal;"01484818";0,128;Q4;12;126;375;1108;65;247;0,18;8,79;76,51;0;48;United States;Northern America;"Jobson Publishing Corporation";"1979, 1990-1996, 2007-2023";"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)";"Health Professions; Pharmacology, Toxicology and Pharmaceutics" 2;4700152711;"ASHA Leader";trade journal;"10859586";0,121;Q4;14;49;232;0;17;39;0,02;0,00;85,00;0;7;United States;Northern America;"American Speech-Language-Hearing Association (ASHA)";"2005-2023";"Speech and Hearing (Q4)";"Health Professions" 3;19700174658;"Regulatory Rapporteur";trade journal;"17428955";0,101;Q4;7;69;167;715;3;96;0,03;10,36;61,19;0;9;United Kingdom;Western Europe;"TOPRA";"2010-2022";"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Pharmacy (Q4)";"Health Professions; Pharmacology, Toxicology and Pharmaceutics" 4;21243;"Pharmacy Times";trade journal;"00030627";0,100;Q4;8;62;341;387;1;233;0,00;6,24;63,16;0;7;United States;Northern America;"Intellisphere LLC";"1977-1987, 2007-2021, 2023";"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)";"Health Professions; Pharmacology, Toxicology and Pharmaceutics"